(Q45129989)

9 December 2017

title

Anti-rheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis (English)

1 reference

9 December 2017

1 reference

1 reference

1 reference

congestive heart failure

1 reference

Bernatsky S

1

1 reference

9 December 2017

Hudson M

series ordinal

2

1 reference

9 December 2017

Suissa S

series ordinal

3

1 reference

9 December 2017

publication date

22 March 2005

1 reference

9 December 2017

1 reference

9 December 2017

volume

44

1 reference

9 December 2017

issue

5

1 reference

9 December 2017

page(s)

677-680

1 reference

Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH610

Cardiac involvement in systemic autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH610

Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH610

Newer disease-modifying antirheumatic drugs and the risk of serious hepatic adverse events in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH610

Association between naproxen use and protection against acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH610

Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH610

Cyclooxygenase-2--specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH610

Coxibs and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH610

Regular review: medical management of osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH610

Characteristics of patients with rheumatoid arthritis in France: a study of 1109 patients managed by hospital based rheumatologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH610

Care and outcomes of patients newly hospitalized for heart failure in the community treated by cardiologists compared with other specialists

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH610

Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failu

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH610

10.1093/RHEUMATOLOGY/KEH610

21 January 2018

Identifiers

DOI

1 reference

9 December 2017

1 reference